Justin Grant, PhD, and David Jaffray, PhD from STTARR speak about the future of personalized medicine with Aspect’s Compact MRI for preclinical research

Erez Hasnis, MD., PhD., Gastroenterologist at Rambam Medical Center, Haifa, Israel., Research Fellow at the Technion faculty of medicine speaks about the benefits in working with Aspect’s Compact MRI System for preclinical research.

Ananth Annapragada, PhD, Professor of Radiology and Director of Basic Research in the Edward B. Singleton Department of Pediatric Radiology at Texas Childrens Hospital presents at the recent Human Placenta Project at NIH . Prof. Annapragada provides data comparing Aspect 1.0 Tesla MRI images with data from a competitors high field 9.4 Tesla.

The Aspect 1.0T image data shows the exquisite high quality research that can be performed at lower fields and that for certain experiments higher field is not necessary.

David Jaffray, PhD and Justin Grant, PhD from STTARR speak about the benefits of Compact MRI for preclinical research, ease of use, low maintenance and much more

Yuval Shaked, PhD, Associate Professor, Vice Dean for Research, Department of Cell Biology and Cancer Science, Technion – Israel institute of Technology, speaks about the benefits in working with Aspect’s Compact MRI System for preclinical research.

Marc-André Fortin, Ing., Ph.D.
Laval University , Québec, Canada

“My field of research is nanomedicine and nanomaterials for cancer theranostics. I have used Aspect Imaging’s Compact MRI system for 6 years and I am very satisfied with the system’s quality and reliability. It is extremely simple to use and robust, providing reliable and accurate results which I have published in many peer-reviewed journals. I strongly recommend this product for development of contrast agents at clinical magnetic field strengths, for follow-up of tumor growth and engineered biological tissues, or to monitor the implantation of porous bio-materials and/or hydrogels in tissues.”

Grant Dagliyan, DRSc(c), MPH, MS
Associate Director, Molecular Imaging Center
Department of Radiology“The USC Molecular Imaging Center (MIC) has recently added the Aspect MRI for preclinical imaging services. It is extremely robust and user friendly. It perfectly complements our other molecular imaging modalities at the center. The Preclinical Imaging Core is dedicated to research studies of small animals for a variety of applications. The pre-clinical versions of imaging modalities in our facility provide information from studies in pre-clinical models, which can be directly translated to clinical settings.”

Dr. Dario Longo, PhDMolecular Imaging CenterDepartment of Molecular Biotechnology and Health SciencesUniversity of Torino, Torino, Italy“I’ve been working with Aspect Imaging since 2008, collaborating with them for the development of preclinical applications and contrast agents for the M series. I was very enthusiastic since the beginning, due to the very high quality MR images, really unexpected at this field (1T), as well as the easiness of the workflow procedures and optimized scan settings that allow any student to be independent after a short training. A second system was installed several years ago in our clean animal facility, allowing to image immunocompromised mice under SPF conditions and I must say this instrument is really powerful and robust. I’m very satisfied!”

The Laboratory for Experimental Neurosurgery
Faculty of Health Sciences
Ben-Gurion University of the Negev, Beer-Sheva, Israel

“We have an experience with the Aspect Imaging 1T uMRI for several years for the application of pre-clinical brain research. We use the scanner for imaging of brainpathologies in diverse neurological disorders. The quality of the images are good and the software is friendly and easy to use.”

PLEASE PROVIDE US WITH YOUR CONTACT INFORMATION AND AREA OF INTEREST AND WE WILL RESPOND TO YOU SHORTLY

Ask an Application Specialist

We use cookies to offer you a better browsing experience, analyze site traffic, personalize content and serve targeted ads. By using our site, you consent to our use of cookies.
Click here to read our Cookie Policy.